Research on the Application Risks of the Regulatory Mechanism of Embryonic Gene Editing Technology

Yuxiang Hu

doi:10.62051/ijphmr.v6n3.02

Authors

Yuxiang Hu

DOI:

https://doi.org/10.62051/ijphmr.v6n3.02

Keywords:

Embryonic gene editing, Regulatory mechanism, Off-target effect, Chimerism

Abstract

This article takes one of the technical cores - regulatory mechanisms - as the starting point to discuss the direct risks such as off target and chimerism caused by the failure or imperfection of regulatory mechanisms; And analyze the potential medical risks, gene pool changes, ethical risks, and social evolution risks that this technology may bring from the perspectives of personal level, reproductive genetics, ethical and social aspects, and ecological evolution. This article also attempts to propose specific and feasible risk prevention and regulatory measures from the perspectives of technology, evaluation standards, laws and regulations, and social supervision, in order to benefit the cautious and rational use of embryo gene editing technology.

References

[1] Didaer Talanaite, Hongyue Wang, Man Qi, Feng Lan. Generation of a human embryonic stem cell line (WAe009-A-3B) carrying homozygous TNNT2 gene knockout by CRISPR/Cas9 editing [J]. Stem cell research, 2025, 86 103729.

[2] Ahmad Pirali, Farnoosh Jafarpour, Mehdi Hajian, Seyed Hossein Hosseini Moghaddam, Reza Moradi, Nima Tanhaie Vash, Mohsen Rahimi Andani, Tayebeh Izadi, Hanieh Shiralian Esfahani, Zahra Safaeinejad, Wilfried Kues, Mohammad Hossein Nasr Esfahani, Shahin Eghbalsaied. Editing the CYP19 Gene in Goat Embryos Using CRISPR/Cas9 and Somatic Cell Nuclear Transfer Techniques [J]. Cellular reprogramming, 2025, 27 (2): 86-93.

[3] Amina Saleem, Mingyu Wei, Muhammad Khawar Abbas, Siyao Zhang, Jiaqi Fan, Yang Xian, Hongfeng Jiang. Generation of a PDK-1 knockout human embryonic stem cell line by CRISPR/(WAe009-A-2K) Cas9 editing [J]. Stem Cell Research, 2025, 83 103642-103642.

[4] Shuaiyan Lu, Ming Chen, Xiaoyu Liu, Jiahang Li, Hui Liu, Shasha Li. Generation of a BEST1 Pr-EGFP reporter human embryonic stem cell line via CRISPR/Cas9 editing [J]. Stem Cell Research, 2025, 82 103625-103625.

[5] Takayuki Sakurai, Norio Takei, Yangxuan Wei, Marina Hayashi, Akiko Kamiyoshi, Hisaka Kawate, Satoshi Watanabe, Masahiro Sato, Takayuki Shindo. Efficient genome editing of two-cell mouse embryos via modified CRISPR/Cas electroporation [J]. Scientific reports, 2024, 14 (1): 30347.

[6] Siyao Zhang, Jiaqi Fan, Hairui Sun, Xiaoyan Hao, Yihua He. Generation of a TSC2 knockout embryonic stem cell line by CRISPR/Cas9 editing [J]. Stem Cell Research, 2024, 77 103399-.

[7] Citra N.Z. Mattar, Wei Leong Chew, Poh San Lai. Embryo and fetal gene editing: Technical challenges and progress toward clinical applications [J]. Molecular Therapy - Methods & Clinical Development, 2024, 32 (2): 101229-.

[8] Daniel J Davis, James F McNew, Jennifer N Walls, Christine E Bethune, Payton S Oswalt, Elizabeth C Bryda. CRISPR-Cas9 Genome Editing of Rat Embryos using Adeno-Associated Virus (AAV) and 2-Cell Embryo Electroporation [J]. Journal of visualized experiments: JoVE, 2024, (205):

[9] Kubikova Nada, Keefe David L, Wells Dagan, Oktay Kutluk H, Feinberg Eve C. Should we use CRISPR gene editing in human embryos? [J]. Fertility and sterility, 2023, 120 (4):

[10] Sadeghi Mohammad Reza. Technical Problems and Ethical Concerns Regarding Gene Editing in Human Germlines and Embryos [J]. Journal of reproduction & infertility, 2023, 24 (3): 145-146.